The Journal of Immunology, Vol 157, Issue 11 4876-4884, Copyright © 1996 by American Association of Immunologists

ARTICLES

Disregulated expression of CD43 (leukosialin, sialophorin) in the B cell lineage leads to immunodeficiency

JR Ostberg, LL Dragone, T Driskell, JA Moynihan, R Phipps, RK Barth and JG Frelinger
Department of Microbiology and Immunology, and the Cancer Center, University of Rochester Medical Center, NY 14642, USA.

Leukosialin (CD43 or sialophorin) is a cell surface sialoglycoprotein implicated in cell adhesion and proliferation whose tightly regulated expression in B lymphocytes is likely important for their normal development and/or function. To examine the physiologic role of mouse CD43 (mCD43) in vivo, we exploited transgenic (TG) mice whose developmental expression of mCD43 was extended during B cell differentiation so that mCD43 was now expressed on peripheral B cells. Despite having increased B cells, localization of lymphocytes in the TG spleens appeared normal by immunocytochemistry with anti-CD4, anti-CD8, and anti-B220 mAbs. However, the numbers of splenic germinal centers and the resting sera Ig levels were decreased in the TG mice compared with littermate controls. TG mice had decreased humoral responses to the T-dependent Ags keyhole limpet hemocyanin and OVA, as well as reduced Ag-specific B cell numbers. In contrast, in vitro LPS stimulation of purified TG or control B cells resulted in similar proliferation and IgM responses. Thus, the alteration of B cell mCD43 expression that resulted in profound immunodeficiency in vivo was not due to absolute defects in B cell development or Ab production. However, TG B cells had a decreased ability to homotypically aggregate and to present Ag to the T cell hybridoma B3Z. These data suggest that the immunodeficiency seen in vivo is due to the anti-adhesive forces of mCD43 preventing normal T-B cell interaction. This likely reflects a general property of mucins in regulating cell interactions.

This article has been cited by other articles:

				L. L. Dragone, M. D. Myers, C. White, T. Sosinowski, and A. Weiss Src-Like Adaptor Protein Regulates B Cell Development and Function J. Immunol., January 1, 2006; 176(1): 335 - 345. [Abstract] [Full Text] [PDF]

				A. K. Randhawa, H. J. Ziltener, J. S. Merzaban, and R. W. Stokes CD43 Is Required for Optimal Growth Inhibition of Mycobacterium tuberculosis in Macrophages and in Mice J. Immunol., August 1, 2005; 175(3): 1805 - 1812. [Abstract] [Full Text] [PDF]

				D. A. Carlow, S. Y. Corbel, and H. J. Ziltener Absence of CD43 Fails to Alter T Cell Development and Responsiveness J. Immunol., January 1, 2001; 166(1): 256 - 261. [Abstract] [Full Text] [PDF]

				M. Fukuoka, K. Fukudome, Y. Yamashita, M. Tokushima, K. Miyake, and M. Kimoto Antiadhesive function of 130-kd glycoform of CD43 expressed in CD4 T-lymphocyte clones and transfectant cell lines Blood, December 15, 2000; 96(13): 4267 - 4275. [Abstract] [Full Text] [PDF]

				J. Walker and J. M. Green Structural Requirements for CD43 Function J. Immunol., April 1, 1999; 162(7): 4109 - 4114. [Abstract] [Full Text] [PDF]

				A. I. Sperling, J. R. Sedy, N. Manjunath, A. Kupfer, B. Ardman, and J. K. Burkhardt Cutting Edge: TCR Signaling Induces Selective Exclusion of CD43 from the T Cell-Antigen-Presenting Cell Contact Site J. Immunol., December 15, 1998; 161(12): 6459 - 6462. [Abstract] [Full Text] [PDF]